Episode Details
Back to Episodes
FDA Approves First Alzheimer’s Drug in Years | Jersey News
Published 1 month, 1 week ago
Description
FDA just approved Leqembi, the first drug in years to target Alzheimer’s by clearing brain amyloid plaques—offering hope for early-stage patients, but with caveats: modest benefits, serious side effects, and a staggering $56K annual cost. The approval marks a breakthrough, yet real-world access, safety monitoring, and ongoing research will determine its true impact on the fight against this devastating disease.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/f3bae4381c5860d1